157 related articles for article (PubMed ID: 33797002)
1. Association Between Adjuvant Therapy and Survival in Stage II-III Endometrial Cancer: Influence of Malignant Peritoneal Cytology.
Matsuo K; Matsuzaki S; Nusbaum DJ; Roman LD; Wright JD; Harter P; Klar M
Ann Surg Oncol; 2021 Nov; 28(12):7591-7603. PubMed ID: 33797002
[TBL] [Abstract][Full Text] [Related]
2. Malignant peritoneal cytology and increased mortality risk in stage I non-endometrioid endometrial cancer.
Matsuo K; Nusbaum DJ; Matsuzaki S; Chang EJ; Roman LD; Wright JD; Harter P; Klar M
Gynecol Oncol; 2020 Oct; 159(1):43-51. PubMed ID: 32690393
[TBL] [Abstract][Full Text] [Related]
3. Malignant peritoneal cytology and decreased survival of women with stage I endometrioid endometrial cancer.
Matsuo K; Matsuzaki S; Nusbaum DJ; Machida H; Nagase Y; Grubbs BH; Roman LD; Wright JD; Harter P; Klar M
Eur J Cancer; 2020 Jul; 133():33-46. PubMed ID: 32434109
[TBL] [Abstract][Full Text] [Related]
4. Prognosis and treatment of positive peritoneal cytology in early endometrial cancer: matched cohort analyses from the National Cancer Database.
Seagle BL; Alexander AL; Lantsman T; Shahabi S
Am J Obstet Gynecol; 2018 Mar; 218(3):329.e1-329.e15. PubMed ID: 29223598
[TBL] [Abstract][Full Text] [Related]
5. Significance of abnormal peritoneal cytology on survival of women with stage I-II endometrioid endometrial cancer.
Matsuo K; Yabuno A; Hom MS; Shida M; Kakuda M; Adachi S; Mandelbaum RS; Ueda Y; Hasegawa K; Enomoto T; Mikami M; Roman LD
Gynecol Oncol; 2018 May; 149(2):301-309. PubMed ID: 29605499
[TBL] [Abstract][Full Text] [Related]
6. Prognosis and adjuvant chemotherapy for patients with malignant peritoneal cytology in early-stage non-endometrioid endometrial cancer.
Tang X; Li N; Hu Y
Eur J Surg Oncol; 2023 Nov; 49(11):107071. PubMed ID: 37708662
[TBL] [Abstract][Full Text] [Related]
7. Trends in peritoneal cytology evaluation at hysterectomy for endometrial cancer in the United States.
Matsuo K; Klar M; Harter P; Miller H; Nusbaum DJ; Matsuzaki S; Roman LD; Wright JD
Gynecol Oncol; 2021 Jun; 161(3):710-719. PubMed ID: 33726962
[TBL] [Abstract][Full Text] [Related]
8. Role of adjuvant therapy in stage IIIC2 endometrial cancer.
Bogani G; Cappuccio S; Casarin J; Narasimhulu DMM; Cilby WA; Glaser GE; Weaver AL; McGree ME; Keeney GL; Weroha J; Petersen IA; Mariani A
Int J Gynecol Cancer; 2020 Aug; 30(8):1169-1176. PubMed ID: 32646864
[TBL] [Abstract][Full Text] [Related]
9. Clinico-pathological significance of suspicious peritoneal cytology in endometrial cancer.
Matsuo K; Matsuzaki S; Miller H; Nusbaum DJ; Walia S; Matsuzaki S; Shimada M; Klar M; Roman LD
J Surg Oncol; 2021 Sep; 124(4):687-698. PubMed ID: 34118157
[TBL] [Abstract][Full Text] [Related]
10. Peritoneal cytology: a risk factor of recurrence for non-endometrioid endometrial cancer.
Han KH; Park NH; Kim HS; Chung HH; Kim JW; Song YS
Gynecol Oncol; 2014 Aug; 134(2):293-6. PubMed ID: 24854062
[TBL] [Abstract][Full Text] [Related]
11. The prognostic role of peritoneal cytology in stage IA endometrial endometrioid carcinomas.
Wang L; Li L; Wu M; Lang J
Curr Probl Cancer; 2020 Apr; 44(2):100514. PubMed ID: 31753315
[TBL] [Abstract][Full Text] [Related]
12. Defining the survival benefit of adjuvant pelvic radiotherapy and chemotherapy versus chemotherapy alone in stages III-IVA endometrial carcinoma.
Xiang M; English DP; Kidd EA
Gynecol Oncol; 2019 Sep; 154(3):487-494. PubMed ID: 31257010
[TBL] [Abstract][Full Text] [Related]
13. Positive peritoneal cytology is highly predictive of prognosis and relapse patterns in stage III (FIGO 2009) endometrial cancer.
Milgrom SA; Kollmeier MA; Abu-Rustum NR; Makker V; Gardner GJ; Barakat RR; Alektiar KM
Gynecol Oncol; 2013 Jul; 130(1):49-53. PubMed ID: 23603151
[TBL] [Abstract][Full Text] [Related]
14. Significance of Malignant Peritoneal Cytology on Survival of Women with Uterine Sarcoma.
Matsuo K; Matsuzaki S; Nusbaum DJ; Ki S; Chang EJ; Klar M; Roman LD
Ann Surg Oncol; 2021 Mar; 28(3):1740-1748. PubMed ID: 33063261
[TBL] [Abstract][Full Text] [Related]
15. The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer.
Alvarez Secord A; Havrilesky LJ; Bae-Jump V; Chin J; Calingaert B; Bland A; Rutledge TL; Berchuck A; Clarke-Pearson DL; Gehrig PA
Gynecol Oncol; 2007 Nov; 107(2):285-91. PubMed ID: 17688923
[TBL] [Abstract][Full Text] [Related]
16. The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancer.
Havrilesky LJ; Cragun JM; Calingaert B; Alvarez Secord A; Valea FA; Clarke-Pearson DL; Berchuck A; Soper JT
Gynecol Oncol; 2007 Feb; 104(2):401-5. PubMed ID: 17014898
[TBL] [Abstract][Full Text] [Related]
17. Malignant peritoneal cytology in endometrial cancer: a contemporary review.
Guo XM; Roman LD; Klar M; Wright JD; Matsuo K
Expert Rev Anticancer Ther; 2022 Sep; 22(9):947-955. PubMed ID: 35862462
[TBL] [Abstract][Full Text] [Related]
18. Role of brachytherapy in stage III endometrial cancer treated with adjuvant chemotherapy: Identifying factors predictive of a survival benefit.
Xiang M; English DP; Kidd EA
Brachytherapy; 2021; 20(4):701-709. PubMed ID: 33781714
[TBL] [Abstract][Full Text] [Related]
19. Influence of body mass index on clinicopathologic features, surgical morbidity and outcome in patients with endometrial cancer.
Akbayır O; Corbacıoglu Esmer A; Numanoglu C; Cılesız Goksedef BP; Akca A; Bakır LV; Kuru O
Arch Gynecol Obstet; 2012 Nov; 286(5):1269-76. PubMed ID: 22729137
[TBL] [Abstract][Full Text] [Related]
20. Prognosis and adjuvant chemotherapy for patients with positive peritoneal cytology in stage IA endometrial cancer.
Kanno M; Yunokawa M; Nakabayashi M; Omi M; Ikki A; Mizusaki M; Nishimura M; Shimizu Y; Okamoto K; Tanaka Y; Fusegi A; Netsu S; Kurita T; Aoki Y; Tanigawa T; Matoda M; Okamoto S; Nomura H; Omatsu K; Sugiyama Y; Utsugi K; Takeshima N; Kanao H
Sci Rep; 2022 Jan; 12(1):166. PubMed ID: 34997003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
